Literature DB >> 18285832

Uptake of testing for BRCA1/2 mutations in South East Scotland.

Susan M Holloway1, Birgitta Bernhard, Harry Campbell, Wayne W K Lam.   

Abstract

We investigated the uptake of genetic testing by 54 families in South East Scotland with a BRCA1/2 mutation. At a median of 37 months since identification of the mutation, the overall rate of uptake of testing in 269 eligible family members was 32%. First-degree relatives were significantly (P<0.05) less likely to be referred for genetic counselling in more, compared to less, socioeconomically deprived families (46 versus 68%). Among relatives who attended for genetic counselling, females were more likely to be tested than males (76 versus 53%; P<0.05) and relatives with children more than those without children (82 versus 53%; P<0.001). Tested relatives were older than relatives who did not undergo testing (mean 41.9 versus 36.8 years, P<0.05) but did not differ in degree of relationship to the index case or in socioeconomic deprivation. Our results confirm the findings from other studies of substantially lower rates of uptake of genetic testing for BRCA1/2 mutations than anticipated in earlier predictions. Relatives in more socioeconomically deprived families were less likely to be referred for genetic counselling, which is a matter of concern. This may be partly the result of a lack of understanding of the testing process. Cascading currently does not work in breast cancer families and further work is required to investigate intrafamilial communication patterns, testing behaviour and counselling strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285832     DOI: 10.1038/ejhg.2008.17

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  6 in total

1.  The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.

Authors:  Fred H Menko; Jacqueline A Ter Stege; Lizet E van der Kolk; Kiki N Jeanson; Winnie Schats; Daoud Ait Moha; Eveline M A Bleiker
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

Review 2.  Predictors of genetic testing decisions: a systematic review and critique of the literature.

Authors:  Kate Sweeny; Arezou Ghane; Angela M Legg; Ho Phi Huynh; Sara E Andrews
Journal:  J Genet Couns       Date:  2014-04-11       Impact factor: 2.537

3.  Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.

Authors:  David E O'Reilly; Lucy Dooley; Geoffrey A Watson; Roisin Clarke; Amy Nolan; Carmel Nolan; Eileen Berkeley; Michael Farrell; Trudi McDevitt; Melissa Rogers; Catherine Clabby; David J Gallagher
Journal:  Ir J Med Sci       Date:  2022-10-19       Impact factor: 2.089

4.  Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.

Authors:  Judit Sanz; Teresa Ramón y Cajal; Asunción Torres; Esther Darder; Neus Gadea; Angela Velasco; Daniel Fortuny; Consol López; David Fisas; Joan Brunet; M Carmen Alonso; Judith Balmaña
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

5.  Painting a portrait: Analysis of national health survey data for cancer genetic counseling.

Authors:  Monica H Stamp; Ora K Gordon; Christopher P Childers; Kimberly K Childers
Journal:  Cancer Med       Date:  2019-02-07       Impact factor: 4.452

Review 6.  Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.

Authors:  Lauren C Tindale; Almira Zhantuyakova; Stephanie Lam; Michelle Woo; Janice S Kwon; Gillian E Hanley; Bartha Knoppers; Kasmintan A Schrader; Stuart J Peacock; Aline Talhouk; Trevor Dummer; Kelly Metcalfe; Nora Pashayan; William D Foulkes; Ranjit Manchanda; David Huntsman; Gavin Stuart; Jacques Simard; Lesa Dawson
Journal:  Curr Oncol       Date:  2022-06-30       Impact factor: 3.109

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.